The Great RIF(T): One FDA Division’s Destruction and What it Could Mean for Generic Drugs
The FDA Law Blog
APRIL 8, 2025
Karst The FDA Reduction-in-Force (Termination)or RIF(T)announced last week has resulted in countless stories in the press and on personal LinkedIn accounts from those RIFd. As folks steeped in the world of generic drugs And Hatch-Waxman know, theres a lot that happens before FDA can take action on an ANDA.
Let's personalize your content